Torsades de pointes overview

Revision as of 01:38, 15 October 2012 by Charmaine Patel (talk | contribs) (Created page with "__NOTOC__ {{Torsades de pointes}} {{CMG}} ==Overview== '''Torsade de pointes''' in French means "Twisting of the Points". It is characterized by a polymorphic [[ventricular t...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Torsades de pointes Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Torsades de pointes from other Diseases

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples

Echocardiography

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Torsades de pointes overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Torsades de pointes overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Torsades de pointes overview

CDC on Torsades de pointes overview

Torsades de pointes overview in the news

Blogs on Torsades de pointes overview

Directions to Hospitals Treating Torsades de pointes

Risk calculators and risk factors for Torsades de pointes overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Torsade de pointes in French means "Twisting of the Points". It is characterized by a polymorphic ventricular tachycardia and can occur in the congenital long QT syndromes, electrolyte abnormalities (hypomagnesemia, hypokalemia), usage of certain drugs like antiarrhythmic (quinidine), nonsedating antihistamines (terfenadine); antibiotics (erythromycin) and neuroleptics (thioridazine). Torsade de pointes is characterized by constantly changing rhythm amplitude. The changing rhythm amplitudes comes from the ventricular depolarizing waves constantly shifting its axis. The underlying mechanism is thought to be triggered activity arising as a consequence of early after-depolarizations. Torsade de pointes is typically initiated by a short-long-short interval. A ventricle extrasystole (first beat: short) is followed by a compensatory pause. The following beat (second beat: long) has a longer QT interval. If the next beat follows shortly thereafter, there is a good chance that this third beat falls within the QT interval, resulting in the R on T phenomenon and subsequent Torsade de pointes. During Torsade de pointes the ventricles depolarize in a circular fashion resulting in QRS complexes with a continuously turning heart axis around the baseline (hence the name Torsade de Pointes). An understanding of the patho-physiology has led to development of treatment modalities like pacing, isoproterenol and drugs like magnesium and beta blockers. Although Torsades de Pointes (TdP) is a rare ventricular arrhythmia, it can degenerate into ventricular fibrillation, leading to death without rapid medical intervention. TdP is associated with long QT syndrome, a condition whereby prolonged QT intervals are visible on the ECG. Also, a more rare form of short coupled Torsade de pointes has been observed.[1]

References

  1. Leenhardt A, Glaser E, Burguera M, Nuernberg M, Maison-Blanche P, and Coumel P. Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation 1994 Jan; 89(1) 206-15. PMID 8281648